| Indicators | Browse All

Alcon Inc. (ALC)

Healthcare | Medical Instruments & Supplies | Geneva, Switzerland | NYSE
66.86 USD -2.14 (-3.101%) ⇩ (July 14, 2026, 4 p.m. EDT)
After hours: 67.44 +0.58 (0.861%) ⇧ (July 14, 2026, 7:59 p.m. EDT)
Short-term:★★⯪☆☆Long-term:★★★☆☆Dividends:★★★☆☆
Hot Take ↕ | July 11, 2026, 6:17 a.m. EDT

Alcon presents a compelling value story obscured by recent operational headwinds. The core thesis rests on the massive gap between the forward P/E of 17 and the trailing P/E of 40, driven by a sharp contraction in earnings growth (-46%) while revenue continues to expand (+9%). This divergence suggests the market has priced in a temporary earnings stumble rather than a permanent business decline, especially given the robust free cash flow and healthy balance sheet. The long-term rating is solid because the company retains its dominant market position in ophthalmics, and the valuation discount offers a margin of safety if the earnings recovery aligns with the analyst consensus. However, the short-term outlook remains neutral due to the immediate pressure of declining earnings and the statistical forecast leaning slightly negative for the next month. The options market confirms this hesitation, with traders buying protection only at extreme lows while betting on a steady grind higher toward the $70-$75 resistance zone. Investors should view the current dip as a buying opportunity for a multi-year hold, but patience is required for the immediate catalyst to materialize.
Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL_90 ✓0.139696
AutoETS0.154560
AutoARIMA0.154561
MSTL_90_1260.155421
AutoTheta0.156704
MSTL0.159131
MSTL_1260.167196

Forecast horizon: 60 days | Selected: MSTL_90

Forecast Reliability
Score 51%
H-stat 1.75
Ljung-Box p 0.000
Jarque-Bera p 0.045
Excess Kurtosis -0.33
Attribute Value
Sector Healthcare
Ex Dividend Date 2026-05-05
Last Dividend Date 2026-05-04
Debt to Equity Ratio 23.774
Revenue per Share 21.648
Market Cap 32,607,623,168
Trailing P/E 41.27
Forward P/E 16.84
Beta 0.70
Profit Margins 7.70%
Website https://www.alcon.com

As of July 11, 2026, 6:17 a.m. EDT: Speculators are positioning for a range-bound to slightly bullish outcome, heavily favoring calls over puts. The call chain shows significant open interest at strikes 70 and 75, suggesting a floor around current prices with upside targets near 10%. Conversely, put volume is concentrated deep out-of-the-money (strikes 37.5 and 42.5), indicating a belief that a crash to these levels is unlikely. Implied volatility is elevated for longer-dated contracts, reflecting uncertainty about the path to the 2027 earnings recovery.

Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
0.48% 0.48% 0.38% 0.34%
Dividend History
Date Dividend Yield %
2026-05-05 0.358 0.480860
2025-05-13 0.331 0.354960
2024-05-14 0.264 0.295699
2023-05-10 0.236 0.292659
2022-05-03 0.205 0.288895
2021-05-04 0.110 0.147592
Additional Data
dividendRate 0.36
dividendYield 0.52
exDividendDate 2026-05-06
trailingAnnualDividendRate 0.353
trailingAnnualDividendYield 0.0051159416
lastDividendValue 0.358
lastDividendDate 2026-05-05
dividendDate 2026-05-07

Info Dump

Attribute Value
52 Week Change -0.19720769
Address1 Chemin de Blandonnet 8
Address2 Vernier
All Time High 101.1
All Time Low 39.37
Ask 0.0
Ask Size 300
Audit Risk 9
Average Analyst Rating 1.5 - Buy
Average Daily Volume10 Day 2,208,540
Average Daily Volume3 Month 2,116,072
Average Volume 2,116,072
Average Volume10Days 2,208,540
Beta 0.703
Bid 0.0
Bid Size 400
Board Risk 4
Book Value 45.38
City Geneva
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 3
Country Switzerland
Crypto Tradeable 0
Currency USD
Current Price 66.86
Current Ratio 2.204
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 67.98
Day Low 66.85
Debt To Equity 23.774
Display Name Alcon
Dividend Date 1,778,112,000
Dividend Rate 0.36
Dividend Yield 0.52
Earnings Call Timestamp End 1,778,068,800
Earnings Call Timestamp Start 1,778,068,800
Earnings Growth -0.446
Earnings Quarterly Growth -0.46
Earnings Timestamp 1,778,011,200
Earnings Timestamp End 1,778,011,200
Earnings Timestamp Start 1,778,011,200
Ebitda 2,312,999,936
Ebitda Margins 0.21751
Enterprise To Ebitda 15.656
Enterprise To Revenue 3.405
Enterprise Value 36,211,621,888
Eps Current Year 3.46727
Eps Forward 3.97117
Eps Trailing Twelve Months 1.62
Esg Populated 0
Ex Dividend Date 1,778,025,600
Exchange NYQ
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 66.8188
Fifty Day Average Change 0.04119873
Fifty Day Average Change Percent 0.0006165739
Fifty Two Week Change Percent -19.720768
Fifty Two Week High 92.55
Fifty Two Week High Change -25.690002
Fifty Two Week High Change Percent -0.2775797
Fifty Two Week Low 61.835
Fifty Two Week Low Change 5.0250015
Fifty Two Week Low Change Percent 0.08126468
Fifty Two Week Range 61.835 - 92.55
Financial Currency USD
First Trade Date Milliseconds 1,554,816,600,000
Five Year Avg Dividend Yield 0.29
Float Shares 486,149,114
Forward Eps 3.97117
Forward P E 16.836348
Free Cashflow 1,225,500,032
Full Exchange Name NYSE
Full Time Employees 25,000
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,782,864,000
Gross Margins 0.56141
Gross Profits 5,969,999,872
Has Pre Post Market Data 1
Held Percent Insiders 0.0017499999
Held Percent Institutions 0.66424006
Implied Shares Outstanding 487,700,000
Industry Medical Instruments & Supplies
Industry Disp Medical Instruments & Supplies
Industry Key medical-instruments-supplies
Is Earnings Date Estimate 0
Language en-US
Last Dividend Date 1,777,939,200
Last Dividend Value 0.358
Last Fiscal Year End 1,767,139,200
Long Business Summary Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Long Name Alcon Inc.
Market us_market
Market Cap 32,607,623,168
Market State PREPRE
Max Age 86,400
Message Board Id finmb_694234
Most Recent Quarter 1,774,915,200
Net Income To Common 819,000,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 33,688,514,056
Number Of Analyst Opinions 15
Open 67.78
Operating Cashflow 2,304,999,936
Operating Margins 0.12195
Overall Risk 4
Payout Ratio 0.2039
Peg Ratio 1.52
Phone 41 589 112 110
Post Market Change 0.5755005
Post Market Change Percent 0.86075455
Post Market Price 67.4355
Post Market Time 1,784,073,541
Previous Close 69.0
Price Eps Current Year 19.283184
Price Hint 2
Price To Book 1.4733362
Price To Sales Trailing12 Months 3.0663552
Profit Margins 0.077020004
Quick Ratio 1.221
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 1.53846
Region US
Regular Market Change -2.14
Regular Market Change Percent -3.10145
Regular Market Day High 67.98
Regular Market Day Low 66.85
Regular Market Day Range 66.85 - 67.98
Regular Market Open 67.78
Regular Market Previous Close 69.0
Regular Market Price 66.86
Regular Market Time 1,784,059,202
Regular Market Volume 3,401,459
Return On Assets 0.02545
Return On Equity 0.037100002
Revenue Growth 0.094
Revenue Per Share 21.648
Sand P52 Week Change 0.20365608
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 1
Shares Outstanding 487,700,000
Shares Percent Shares Out 0.021300001
Shares Short 8,622,220
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 5,637,580
Short Name Alcon Inc.
Short Ratio 5.73
Source Interval 15
Symbol ALC
Target High Price 107.4
Target Low Price 66.0
Target Mean Price 87.922
Target Median Price 88.0
Total Cash 1,659,000,064
Total Cash Per Share 3.402
Total Debt 5,262,000,128
Total Revenue 10,634,000,384
Tradeable 0
Trailing Annual Dividend Rate 0.353
Trailing Annual Dividend Yield 0.0051159416
Trailing Eps 1.62
Trailing P E 41.271606
Trailing Peg Ratio 1.5501
Triggerable 1
Two Hundred Day Average 75.25205
Two Hundred Day Average Change -8.392052
Two Hundred Day Average Change Percent -0.11151924
Type Disp Equity
Volume 3,401,459
Website https://www.alcon.com
Zip 1,214